Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer

The main goal of this study is to investigate the proportion of participants with locally advanced gastric and gastroesophageal adenocarcinoma without previous treatment during the last 5 years who can tolerate all planned cycles of chemotherapy and radical surgical treatment who will be prospectively randomized into two groups to undergo one of two chemotherapy regimens, followed by surgery: 1. 8 cycles of Total Neoadjuvant ChemoTherapy (TNT) with 5-Fluorouracil (5-FU), Leucovorin, Oxaliplatin, and Docetaxel (FLOT) followed by surgery. 2. 4 cycles of Neoadjuvant FLOT chemotherapy scheme preo

Trial Details

NCT ID
NCT06028737
Phase
PHASE2 / PHASE3
Sponsor
Ukrainian Society of Clinical Oncology
Status
RECRUITING
Cancer Type
Gastric Cancer
Interventions
  • Docetaxel
  • Oxaliplatin
  • Leucovorin
  • Fluorouracil
Locations (sample)
  • Vilnius, Lithuania|54.68916,25.2798
  • Kyiv, Ukraine|50.45466,30.5238

Key Eligibility Criteria

  • Tumor spread according to TNM: ≥cT3 and/or ≥cN0 and M0 (except of invasion of the common hepatic artery, celiac trunk, proximal part of the splenic…
  • Performance status by Eastern Cooperative Oncology Group (ECOG): 0 - 1;
  • Histologically confirmed gastric adenocarcinoma or gastroesophageal junction (Siewert type 2/3) adenocarcinoma.
  • Differentiation grade: G0 - G4;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Gastric Cancer Trials on Trialify →